A detailed history of Chilton Investment CO Inc. transactions in Amgen Inc stock. As of the latest transaction made, Chilton Investment CO Inc. holds 1,307 shares of AMGN stock, worth $384,950. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,307
Previous 1,307 -0.0%
Holding current value
$384,950
Previous $408,000 3.19%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $13,137 - $15,965
50 Added 3.98%
1,307 $408,000
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $1.48 Million - $1.79 Million
-5,521 Reduced 81.45%
1,257 $357,000
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $1.4 Million - $1.58 Million
5,477 Added 420.98%
6,778 $1.95 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $4,373 - $5,429
-20 Reduced 1.51%
1,301 $349,000
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $283,050 - $334,701
1,321 New
1,321 $293,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Chilton Investment CO Inc. Portfolio

Follow Chilton Investment CO Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Investment CO Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chilton Investment CO Inc. with notifications on news.